AGY — Allergy Therapeutics Share News
0.000.00%
Last trade - 00:00- £669.42m
- £716.72m
- £55.04m
REG - Allergy Therapeutics - Publication of Interim Results Delayed
AnnouncementREG - Allergy Therapeutics - Patients dosed in VLP Peanut PROTECT trial
AnnouncementREG - Allergy Therapeutics - Block Listing Interim Review
AnnouncementRCS - Allergy Therapeutics - PDMR Dealing
AnnouncementREG - Allergy Therapeutics - Result of AGM
AnnouncementREG - Allergy Therapeutics - Half-Year Trading Update 2023
AnnouncementREG - Allergy Therapeutics - NOTICE OF 2022 ANNUAL GENERAL MEETING
AnnouncementREG - AIM Allergy Therapeutics - Suspension - Allergy Therapeutics plc
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Annual Report and Accounts Delayed
AnnouncementREG - Allergy Therapeutics - Director Resignation
AnnouncementREG - Allergy Therapeutics - Key updates on Grass MATA MPL and VLP Peanut
AnnouncementREG - Allergy Therapeutics - Appointment of Non-Executive Directors
AnnouncementREG - Allergy Therapeutics - Appointment of Interim CFO
AnnouncementREG - Allergy Therapeutics - Allergy to resume UK manufacturing production
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
Announcement